A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells

Overview of attention for article published in Pathology & Oncology Research, June 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,963 followers.

A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells https://t.co/ogzOjRFVAY

New article: A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells https://t.co/9UAZjGngLA #AML #leusm #hematology https://t.co/Xx6J4qQ5Ou

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.